These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 1722002

  • 21. Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle.
    Griffin MT, Ehlert FJ.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):221-5. PubMed ID: 1328607
    [Abstract] [Full Text] [Related]

  • 22. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
    Olianas MC, Ingianni A, Maullu C, Adem A, Karlsson E, Onali P.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
    [Abstract] [Full Text] [Related]

  • 23. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [Abstract] [Full Text] [Related]

  • 24. Selectivity of partial agonists related to oxotremorine based on differences in muscarinic receptor reserve between the guinea pig ileum and urinary bladder.
    Ringdahl B.
    Mol Pharmacol; 1987 Apr; 31(4):351-6. PubMed ID: 3574286
    [Abstract] [Full Text] [Related]

  • 25. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: specificity for the NMDA response and role of intracellular messengers.
    Allaoua H, Chaudieu I, Alonso R, Quirion R, Boksa P.
    Synapse; 1993 Sep; 15(1):39-47. PubMed ID: 8310424
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82).
    Mei L, Lai J, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):689-94. PubMed ID: 1704434
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. I. Analysis of agonist sensitivity.
    Olianas MC, Onali P.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):673-9. PubMed ID: 1941616
    [Abstract] [Full Text] [Related]

  • 29. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
    Akam EC, Challiss RA, Nahorski SR.
    Br J Pharmacol; 2001 Feb; 132(4):950-8. PubMed ID: 11181437
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
    Heldman E, Barg J, Fisher A, Levy R, Pittel Z, Zimlichman R, Kushnir M, Vogel Z.
    Eur J Pharmacol; 1996 Feb 22; 297(3):283-91. PubMed ID: 8666061
    [Abstract] [Full Text] [Related]

  • 31. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
    Sharif NA, Williams GW, DeSantis LM.
    Neurochem Res; 1995 Jun 22; 20(6):669-74. PubMed ID: 7566362
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    Vickroy TW, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1984 Jun 22; 229(3):747-55. PubMed ID: 6202869
    [Abstract] [Full Text] [Related]

  • 33. Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor.
    Sykes DA, Dowling MR, Charlton SJ.
    Mol Pharmacol; 2009 Sep 22; 76(3):543-51. PubMed ID: 19498041
    [Abstract] [Full Text] [Related]

  • 34. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF, Davids JH, Elzinga CR, Wolf D, Zaagsma J, Kilbinger H.
    Br J Pharmacol; 1997 Sep 22; 122(1):133-41. PubMed ID: 9298539
    [Abstract] [Full Text] [Related]

  • 35. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
    Hu JR, el-Fakahany EE.
    Mol Pharmacol; 1990 Dec 22; 38(6):895-903. PubMed ID: 1701216
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Structural requirements for muscarinic receptor occupation and receptor activation by oxotremorine analogs in the guinea-pig ileum.
    Ringdahl B.
    J Pharmacol Exp Ther; 1985 Jan 22; 232(1):67-73. PubMed ID: 3965701
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.